Paulas Choice Clear Daily Skin Clearing Treatment

Manufacturer
Paula's Choice, LLC | Thibiant International, Inc.
Effective date
2022-01-06
Label type
HUMAN OTC DRUG LABEL
Version
4
Source
legacy-cache
Hydrated at
2026-08-01 22:18:51

Label at a glance#

ProductPaulas Choice Clear Daily Skin Clearing Treatment
Active ingredientBENZOYL PEROXIDE
Label structure13 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Benzoyl Peroxide 5%

OTC - PURPOSE SECTION

Acne Treatment

INDICATIONS & USAGE SECTION

  • Treats acne.
  • Helps prevent new acne blemishes.
  • Penetrates pores to reduce acne blemishes.

DOSAGE & ADMINISTRATION SECTION

After cleansing with Paula's Choice CLEAR Pore Normalizing Cleanser and exfoliating with Anti-Redness Exfoliating Solution, cover the affected area with a thin layer 1 to 3 times a day. Because excessive drying of the skin may occur, start with 1 appliation daily and then gradually increase to 2 or 3 times daily if needed or as directed by a doctor. If bothersome dryness or peeling occurs, reduce application to once a day or every other day. If going outside, use a sunscreen. If sensitivity develops, discontinue use.

WARNINGS SECTION

For external use only.

OTC - DO NOT USE SECTION

Do not use · on broken skin · on large areas of the body · if you are sensitive to benzoyl peroxide.

OTC - ASK DOCTOR SECTION

If too much skin irritation or skin sensitivity develops or increases.

OTC - WHEN USING SECTION

· Avoid unnecessary sun exposure and use a sunscreen · Avoid contact with eyes, lips and mouthIf contact occure, rinse with water · This product may bleach hair or dyed fabrics · Using other topical acne products at the sam etime or right after use of this product may increase dryness or irritation of the skin. If this occurs, only one drug should be used unless direct by a doctor.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help and contact a Poison Control Center immediately.

OTC - STOP USE SECTION

If too much skin irritation or skin sensitivity develops or increases.

OTHER SAFETY INFORMATION

Store at 20-26ºC (68-77ºF). · You may report serious adverse reactions to 1030 SW 34th Street, Suite A, Renton, WA 98057.

INACTIVE INGREDIENT SECTION

Water, Propulene Glycol, Bisabolol, Allantoin, Acrylates/C10-30 Alkyl Acrylate Crosspolymner, Hydroxyethylcellulose, Sodium Citrate, Laureth-4, Caprylyl Glycol, Hexylene Glycol, Sodium Hydroxide, Disodium EDTA, Phenoxyethanol.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

artwork 1artwork 1artwork 2artwork 2

FDA-Initiated Inactive NDC Indexing#

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 15 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
76144-61176144-611-01, 76144-611-02, 76144-611-03

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 14 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
c54e1971-64e2-2d70-e053-2a95a90a612919ae6ea7-cdd4-69f6-e054-00144ff88e882022-01-06WarningsExact identifier
spl id: c54e1971-64e2-2d70-e053-2a95a90a6129
spl set id: 19ae6ea7-cdd4-69f6-e054-00144ff88e88

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.